Biomea Fusion, Inc. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-27: Form ARS; Period of report 2025-12-31; Description ARS; Document ars_2025.pdf.
- 2025-04-28: Form ARS; Period of report 2024-12-31; Description ARS; Document d896375dars.pdf.
- 2024-04-26: Form ARS; Period of report 2023-12-31; Description ARS; Document d804300dars.pdf.
- 2023-04-28: Form ARS; Period of report 2022-12-31; Description ARS; Document d312740dars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-27 | ARS | 2025-12-31 | ARS | ars_2025.pdf |
| 2025-04-28 | ARS | 2024-12-31 | ARS | d896375dars.pdf |
| 2024-04-26 | ARS | 2023-12-31 | ARS | d804300dars.pdf |
| 2023-04-28 | ARS | 2022-12-31 | ARS | d312740dars.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |